Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients
Introduction: If properly evaluated, chronic kidney disease can be found in up to 50% of patients with systemic sclerosis (SSc). The renal resistive index (RRI) is a marker of intrarenal vascular resistance and can predict SSc-associated vasculopathy. This study aimed to determine the impact of bose...
Saved in:
Main Authors: | Emma Di Poi (Author), GianLuca Colussi (Author), Martina Bertoni (Author), Ivan Giovannini (Author), Barbara Tolusso (Author), Gian Franco Ferraccioli (Author), Elisa Gremese (Author), Salvatore De Vita (Author), Giulio Romano (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neurological involvement in systemic sclerosis. Evidence of a central Raynaud's phenomenon
by: E. Di Poi, et al.
Published: (2001) -
The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis
by: Federico Biscetti, et al.
Published: (2017) -
Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)
by: V. Grattagliano, et al.
Published: (2011) -
Analysis of the kinetic of expression of tristetraprolin and HuR by rheumatoid arthritis patients pheripheral blood mononuclear cells stimulated with lipopolysaccharide
by: M. Fabris, et al.
Published: (2004) -
Vascular involvement in systemic sclerosis (scleroderma)
by: Pattanaik D, et al.
Published: (2011)